Ozempic drug will be a new hope for kidney patients

A new study has shown that Ozemic diabetes drug (whose active ingredient is semaglutide) can be very useful for patients with chronic kidney disease and obesity. In addition to controlling blood sugar, this drug also helps to reduce kidney inflammation, lower blood pressure, and reduce the level of protein in urine.

According to the medical and health news service of Tekna Technology Media, this discovery was the result of a study that was conducted with the aim of investigating the effect of Ozempic on diabetic patients. Researchers found that this drug also has a positive effect on kidney function. This is despite the fact that in recent years Ozempic has been highly regarded for its weight loss properties.

In an international study of more than a hundred patients, it was found that those who received Ozempic had a significant improvement in the condition of their kidneys compared to the group that received a placebo. Among these improvements, we can mention a 52% decrease in protein in the urine (which indicates a decrease in damage to the kidneys).

Researchers believe that Ozempic affects the kidneys in two ways: Direct effect: reducing inflammation in the kidneys and reducing fat around the kidneys, which helps to reduce protein in the urine. And the indirect effect: reducing weight and blood pressure, which helps to improve kidney function. The results of this study are very promising and show that Ozempic can be used as a new treatment for patients with chronic kidney disease. However, more studies are needed to confirm these results and investigate the long-term effects of this drug.

Discovering the new properties of Ozempic in the treatment of kidney diseases is an important step towards improving the quality of life of patients suffering from this disease. By conducting more studies, we can know more precisely the benefits of this drug for patients and introduce it as an effective treatment for chronic kidney disease.
To see the latest news, refer to the scientific news page of Tekna Media.